In particular, we focused on TEM7 for its characterized role in bevacizumab-induced infiltrative growth of GBM [38] and on SNAI gene family due to the role of SNAI1 gene in modulating EMT upon regorafenib treatment of hepatocellular carcinoma cells [39]. This evidence concerns the gene SNAI1 and glioblastoma.